Reginald L. Hardy is Chairman at Brickell Biotech, Inc. (BBI). They have made 1 open-market trade across 1 company since 2021, most recently 2021-12-31.
CIK 0001008105
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $133K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BBI | 433,231 | $1.0M |
Shares reported on the most recent Form 4, priced at the 2022-02-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BBI | BUY | 2021-07-23 | 2021-07-27 | $0.67 | $133K | -3.7% | +4.4% | -22.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.